These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30249539)

  • 1. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
    Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
    Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
    Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
    Ribeiro D; Melão A; Barata JT
    Adv Biol Regul; 2013 May; 53(2):211-22. PubMed ID: 23234870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
    Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
    Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7: Comprehensive review.
    Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
    Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.
    Silva A; Gírio A; Cebola I; Santos CI; Antunes F; Barata JT
    Leukemia; 2011 Jun; 25(6):960-7. PubMed ID: 21455214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.
    Melão A; Spit M; Cardoso BA; Barata JT
    Haematologica; 2016 Nov; 101(11):1368-1379. PubMed ID: 27470599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK-STAT signaling pathways.
    Bonaccorso P; Bugarin C; Buracchi C; Fazio G; Biondi A; Lo Nigro L; Gaipa G
    Cytometry B Clin Cytom; 2020 Nov; 98(6):491-503. PubMed ID: 32479694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7R-Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis.
    Cui G; Shimba A; Ma G; Takahara K; Tani-Ichi S; Zhu Y; Asahi T; Abe A; Miyachi H; Kitano S; Hara T; Yasunaga JI; Suwanai H; Yamada H; Matsuoka M; Ueki K; Yoshikai Y; Ikuta K
    J Immunol; 2020 Feb; 204(4):844-857. PubMed ID: 31924648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia.
    Oliveira ML; Veloso A; Garcia EG; Iyer S; Pereira C; Barreto VM; Langenau DM; Barata JT
    Leukemia; 2022 Jun; 36(6):1533-1540. PubMed ID: 35581375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
    Canté-Barrett K; Spijkers-Hagelstein JA; Buijs-Gladdines JG; Uitdehaag JC; Smits WK; van der Zwet J; Buijsman RC; Zaman GJ; Pieters R; Meijerink JP
    Leukemia; 2016 Sep; 30(9):1832-43. PubMed ID: 27174491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
    Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
    Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.
    Almeida ARM; Neto JL; Cachucho A; Euzébio M; Meng X; Kim R; Fernandes MB; Raposo B; Oliveira ML; Ribeiro D; Fragoso R; Zenatti PP; Soares T; de Matos MR; Corrêa JR; Duque M; Roberts KG; Gu Z; Qu C; Pereira C; Pyne S; Pyne NJ; Barreto VM; Bernard-Pierrot I; Clappier E; Mullighan CG; Grosso AR; Yunes JA; Barata JT
    Nat Commun; 2021 Dec; 12(1):7268. PubMed ID: 34907175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
    Silva A; Laranjeira AB; Martins LR; Cardoso BA; Demengeot J; Yunes JA; Seddon B; Barata JT
    Cancer Res; 2011 Jul; 71(14):4780-9. PubMed ID: 21593192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling.
    Brown VI; Hulitt J; Fish J; Sheen C; Bruno M; Xu Q; Carroll M; Fang J; Teachey D; Grupp SA
    Cancer Res; 2007 Oct; 67(20):9963-70. PubMed ID: 17942929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of
    Kuzilková D; Bugarin C; Rejlova K; Schulz AR; Mei HE; Paganin M; Biffi A; Biondi A; Kalina T; Gaipa G
    Haematologica; 2022 Jun; 107(6):1293-1310. PubMed ID: 34670357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.